Consumer Driven Health Care

In a lawsuit filed Tuesday, Merck becomes the first major drugmaker to challenge Biden's Inflation Reduction Act, which it says "violates the Constitution" by allowing the government to unilaterally impose its preferred price.

Coherus BioSciences will launch Yusimry – used to treat rheumatoid arthritis and psoriasis – which Cuban's Cost Plus Drugs will be offering starting in July.

More than 8% of Americans (aged 18 to 64) have skipped, delayed or reduced the amount of prescribed medication because of cost concerns, according to the CDC.

Four years after a judge recommended the harshest penalty for drug distributor Morris & Dickson for its "cavalier disregard" of rules aimed at preventing opioid abuses, the Drug Enforcement Administration revoked its license.

The uninsured rate fell to 8.4% in 2022 from 9.2% in 2021, but there were disparities linked to ethnicity, says the National Health Interview Survey.

The health care provider plans to open value-based primary care centers in Arkansas, Iowa, Kansas and Virginia, marking CVS' latest move to get further into health care services.